High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute
Davar, Diwakar, Ding, Fei, Saul, Melissa, Sander, Cindy, Tarhini, Ahmad A., Kirkwood, John M., Tawbi, Hussein A.Volume:
5
Langue:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-017-0279-5
Date:
December, 2017
Fichier:
PDF, 1020 KB
english, 2017